Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dolastatin 10
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-15 of 15 for your search:
Start Over
Phase II Study of Dolastatin 10 in Patients with Unresectable or Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 03/2000)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-98062, NCI-T98-0018, T98-0018
Phase II Study of Dolastatin 10 in Patients with Previously Treated Advanced Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-983251, NCCTG-98-32-51
Phase II Study of Dolastatin 10 in Patients with Locally Advanced, Unresectable, or Metastatic Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CHNMC-IRB-98039, NCI-T98-0009, T98-0009
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 9409, UCCRC-9409, NCI-T98-0010, T98-0010, NCT00003557
Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000066708, P30CA022453, WSU-D-1644, NCI-T98-0019, T98-0019, NCT00003626
Phase II Study of Dolastatin 10 in Patients With Advanced Non-Small Cell Lung Cancer (Summary Last Modified 10/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-98070, NCI-T98-0016, T98-0016
Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: DM98-071, P30CA016672, U01CA070172, U01CA063187, MDA-DM-98071, NCI-T98-0028, CDR0000066778, T98-0028, NCT00003677
Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02295, FCCC-98019, NCI-T98-0026, CDR0000066907, NCT00003778
Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067094, P30CA015083, 975002, T98-0024, 372-99, MAYO-975002, NCI-T98-0024, NCT00003914
Phase I Study of Dolastatin 10 for Advanced Solid Tumors (Summary Last Modified 04/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-95045, NCI-T95-0018D, T95-0018
Phase I Study of Dolastatin-10 for Advanced Malignancies (Summary Last Modified 04/98)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-940102, NCI-T95-0007H, T95-0007
Phase I Study of Dolastatin 10 in Children with Refractory Solid Tumors (Summary Last Modified 01/2001)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: CCG-09718
Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Phase: Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: DM98-187, U01CA062461, P30CA016672, MDA-DM-98187, NCI-T98-0001, CDR0000066796, T98-0001, NCT00003693
Start Over